Silexion Therapeutics Corp (SLXN)

Silexion Therapeutics Statistics

Total Valuation

SLXN has a market cap or net worth of $7.50 million. The enterprise value is $285,941.

Market Cap	7.50M
Enterprise Value	285,941

Important Dates

The last earnings date was Wednesday, November 12, 2025, before market open.

Earnings Date	Nov 12, 2025
Ex-Dividend Date	n/a

Share Statistics

SLXN has 3.13 million shares outstanding.

Current Share Class	3.13M
Shares Outstanding	3.13M
Shares Change (YoY)	n/a
Shares Change (QoQ)	+947.99%
Owned by Insiders (%)	n/a
Owned by Institutions (%)	0.92%
Float	3.00M

Valuation Ratios

PE Ratio	n/a
Forward PE	n/a
PS Ratio	n/a
Forward PS	n/a
PB Ratio	1.08
P/TBV Ratio	1.08
P/FCF Ratio	n/a
P/OCF Ratio	n/a
PEG Ratio	n/a

Enterprise Valuation

EV / Earnings	n/a
EV / Sales	n/a
EV / EBITDA	n/a
EV / EBIT	n/a
EV / FCF	n/a

Financial Position

The company has a current ratio of 3.97, with a Debt / Equity ratio of 0.29.

Current Ratio	3.97
Quick Ratio	3.32
Debt / Equity	0.29
Debt / EBITDA	n/a
Debt / FCF	n/a
Interest Coverage	-338.00

Financial Efficiency

Return on equity (ROE) is -771.23% and return on invested capital (ROIC) is -130.60%.

Return on Equity (ROE)	-771.23%
Return on Assets (ROA)	-77.60%
Return on Invested Capital (ROIC)	-130.60%
Return on Capital Employed (ROCE)	-103.38%
Revenue Per Employee	n/a
Profits Per Employee	-$660,500
Employee Count	14
Asset Turnover	n/a
Inventory Turnover	n/a

Taxes

In the past 12 months, SLXN has paid $4,000 in taxes.

Income Tax	4,000
Effective Tax Rate	n/a

Stock Price Statistics

The stock price has decreased by -92.52% in the last 52 weeks. The beta is -0.06, so SLXN's price volatility has been lower than the market average.

Beta (5Y)	-0.06
52-Week Price Change	-92.52%
50-Day Moving Average	3.00
200-Day Moving Average	9.30
Relative Strength Index (RSI)	36.56
Average Volume (20 Days)	61,576

Short Selling Information

The latest short interest is 112,215, so 3.59% of the outstanding shares have been sold short.

Short Interest	112,215
Short Previous Month	91,327
Short % of Shares Out	3.59%
Short % of Float	3.75%
Short Ratio (days to cover)	1.76

Income Statement

Revenue	n/a
Gross Profit	n/a
Operating Income	-9.13M
Pretax Income	-9.24M
Net Income	-9.25M
EBITDA	-9.13M
EBIT	-9.13M
Earnings Per Share (EPS)	-$16.23

Balance Sheet

The company has $9.24 million in cash and $2.03 million in debt, giving a net cash position of $7.22 million or $2.31 per share.

Cash & Cash Equivalents	9.24M
Total Debt	2.03M
Net Cash	7.22M
Net Cash Per Share	$2.31
Equity (Book Value)	6.98M
Book Value Per Share	2.23
Working Capital	8.27M

Cash Flow

In the last 12 months, operating cash flow was -$10.73 million and capital expenditures -$7,000, giving a free cash flow of -$10.74 million.

Operating Cash Flow	-10.73M
Capital Expenditures	-7,000
Free Cash Flow	-10.74M
FCF Per Share	-$3.43

Margins

Gross Margin	n/a
Operating Margin	n/a
Pretax Margin	n/a
Profit Margin	n/a
EBITDA Margin	n/a
EBIT Margin	n/a
FCF Margin	n/a

Dividends & Yields

SLXN does not appear to pay any dividends at this time.

Dividend Per Share	n/a
Dividend Yield	n/a
Dividend Growth (YoY)	n/a
Years of Dividend Growth	n/a
Payout Ratio	n/a
Buyback Yield	n/a
Shareholder Yield	n/a
Earnings Yield	-123.23%
FCF Yield	-143.07%

Analyst Forecast

The average price target for SLXN is $40.50, which is 1,587.50% higher than the current price. The consensus rating is "Strong Buy".

Price Target	$40.50
Price Target Difference	1,587.50%
Analyst Consensus	Strong Buy
Analyst Count	2
Revenue Growth Forecast (5Y)	n/a
EPS Growth Forecast (5Y)	-57.15%

Fair Value

There are several formulas that can be used to estimate the intrinsic value of a stock.

Lynch Fair Value	n/a
Lynch Upside	n/a
Graham Number	n/a
Graham Upside	n/a

Stock Splits

The last stock split was on July 29, 2025. It was a reverse split with a ratio of 1:15.

Last Split Date	Jul 29, 2025
Split Type	Reverse
Split Ratio	1:15

Scores

Altman Z-Score	n/a
Piotroski F-Score	1